Policy / Pricing FDA Achieves Year 1 Goals in Reducing Animal Testing in Drug Development FDASince publishing roadmap last April, agency has successfully launched several key initiatives to replace animal testing with better alternativesPolicy / PricingRead full story pharminent April 20, 2026 (Last updated: April 20, 2026) FDA Since publishing roadmap last April, agency has successfully launched several key initiatives to replace animal testing with better alternatives Policy / PricingRead full story Post navigation Previous: 221: An Interview With Dutch Neurologist Ewout Groen of SMA EuropeNext: Lilly boosts ‘in vivo’ cell therapy capabilities with Kelonia buyout Related Stories Policy / Pricing MFN affecting Swiss medicines access, says Interpharma pharminent August 13, 2026 Policy / Pricing Prior Authorization Metrics Provide New Insights into Insurer Practices, but Gaps Remain pharminent August 13, 2026 Policy / Pricing Trump signs order that nearly halves childhood immunisation coverage pharminent August 11, 2026
